Chronic Kidney Disease

The Pharmacy Times® Chronic Kidney Disease Resource Center is a comprehensive resource for clinical news and expert insights on issues related to long-term disease of the kidneys leading to renal failure.

Latest News

FDA approves REMS modification for sparsentan -- Image credit: wladimir1804 | stock.adobe.com
FDA Approves REMS Modification for Sparsentan in IgA Nephropathy

August 28th 2025

The FDA updated sparsentan's REMS, easing monitoring requirements, enhancing treatment access for IgA nephropathy patients, and supporting kidney function preservation.

Oral metformin tablets (CKD) -- Image credit: Sherry Young | stock.adobe.com
Metformin, Potential Treatment for ADPKD, Currently Undergoing Investigation in Long-Term Efficacy Trial

August 27th 2025

Diagnosis papers for chronic kidney disease (CKD) -- Image credit: Dzmitry | stock.adobe.com
UNI-494 Receives US Patent for Treatment of Chronic Kidney Disease

August 19th 2025

Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers
Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers

August 15th 2025

Patient Perceptions Support Co-Management of Chronic Kidney Disease
Patient Perceptions Support Co-Management of Chronic Kidney Disease

August 14th 2025

Latest CME Events & Activities

More News